Article Text

PROSPECTIV—a pilot trial of a nurse-led psychoeducational intervention delivered in primary care to prostate cancer survivors: study protocol for a randomised controlled trial
  1. Eila Watson1,
  2. Peter Rose2,
  3. Emma Frith1,
  4. Freddie Hamdy3,
  5. David Neal4,
  6. Christof Kastner4,
  7. Simon Russell4,
  8. Fiona M Walter5,
  9. Sara Faithfull6,
  10. Jane Wolstenholme7,
  11. Rafael Perera2,
  12. David Weller8,
  13. Christine Campbell8,
  14. Clare Wilkinson9,
  15. Richard Neal9,
  16. Prasanna Sooriakumaran3,
  17. Hugh Butcher10,
  18. Mike Matthews10
  1. 1Department of Clinical Health Care, Oxford Brookes University, Oxford, UK
  2. 2Department of Primary Health Care, University of Oxford, Oxford, UK
  3. 3Nuffield Department of Surgical Sciences, Oxford University Hospitals Trust, Oxford, UK
  4. 4Department of Surgical Oncology, Cambridge University Hospitals Trust, Cambridge, UK
  5. 5Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
  6. 6Division of Health and Social Care, University of Surrey, Guildford, UK
  7. 7Health Economics Research Unit, University of Oxford, Oxford, UK
  8. 8Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UK
  9. 9North Wales Centre for Primary Care Research, Bangor University, Wrexham, UK
  10. 10Service User Representatives, UK
  1. Correspondence to Professor Eila Watson; ewatson{at}brookes.ac.uk

Abstract

Background Prostate cancer survivors can experience physical, sexual, psychological and emotional problems, and there is evidence that current follow-up practices fail to meet these men's needs. Studies show that secondary and primary care physicians see a greater role for primary care in delivering follow-up, and that primary care-led follow-up is acceptable to men with prostate cancer.

Methods and analysis A two-phase study with target population being men who are 9–24 months from diagnosis. Phase 1 questionnaire aims to recruit 300 men and measure prostate-related quality of life and unmet needs. Men experiencing problems with urinary, bowel, sexual or hormonal function will be eligible for phase 2, a pilot trial of a primary care nurse-led psychoeducational intervention. Consenting eligible participants will be randomised either to intervention plus usual care, or usual care alone (40 men in each arm). The intervention, based on a self-management approach, underpinned by Bandura's Social Cognitive Theory, will provide advice and support tailored to these men's needs and address any problems they are experiencing. Telephone follow-up will take place at 6 months. Study outcomes will be measured by a questionnaire at 7 months. Phase 1 will allow us to estimate the prevalence of urinary, sexual, bowel and hormone-related problems in prostate cancer survivors and the level of unmet needs. ‘Usual care’ will also be documented. Phase 2 will provide information on recruitment and retention, acceptability of the intervention/outcome measures, effect sizes of the intervention and cost-effectiveness data, which is required to inform development of a larger, phase 3 randomised controlled trial. The main outcome of interest is change in prostate-cancer-related quality of life. Methodological issues will also be addressed.

Ethics and dissemination Ethics approval has been gained (Oxford REC A 12/SC/0500). Findings will be disseminated in peer-reviewed journals, at conferences, through user networks and relevant clinical groups.

Trial registration number ISRCTN 97242511.

  • Primary Care
  • Rehabilitation Medicine

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Supplementary materials

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement: